Nordic Nanovector is committed to developing and delivering innovative therapies to patients to address major unmet medical needs. The Company aspires to become a leader in the development of CD37-targeted therapies for hematological cancers and immune diseases.

Biotechnology

Nordic Nanovector

Ludvik Sandnes

Stein Rune Kjelby

margrethe Sørgaard

Lars Nieba

Jostein Dahle

Nordic Nanovector's board of directors has a wealth of experience in the scientific and healthcare industries. Board members have led groups at prestigious hospitals and have been scientists at Norwegian Radium Hospital and Det Norske Radiumhospital. In addition, one board member has experience in finance from their education at INSEAD.

Board of Directors

Leadership Team

CEO and Executive Team

Board of Directors

About

Team members

Other teams at Nordic Nanovector

Leadership Team

CEO and Executive Team